Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.
A Safety and Effectiveness Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Malignant Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia
Sponsor: Alpha Tau Medical LTD.
This NA trial investigates Mucosal Neoplasm of Oral Cavity and Skin Cancer and is currently actively recruiting participants. Alpha Tau Medical LTD. leads this study, which shows 13 recorded versions since 2020 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
13 versions recorded-
Jan 2026 — Present [monthly]
Recruiting NA
-
Dec 2024 — Jan 2026 [monthly]
Recruiting NA
-
Sep 2024 — Dec 2024 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Aug 2023 — Jul 2024 [monthly]
Recruiting NA
▶ Show 8 earlier versions
-
Jul 2022 — Aug 2023 [monthly]
Recruiting NA
-
Mar 2022 — Jul 2022 [monthly]
Recruiting NA
-
Feb 2021 — Mar 2022 [monthly]
Recruiting NA
-
Jan 2021 — Feb 2021 [monthly]
Recruiting NA
-
Aug 2020 — Jan 2021 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jan 2020 — Aug 2020 [monthly]
Not Yet Recruiting NA
-
Jul 2019 — Jan 2020 [monthly]
Not Yet Recruiting NA
-
Apr 2019 — Jul 2019 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Alpha Tau Medical LTD.
For direct contact, visit the study record on ClinicalTrials.gov .